...
机译:新型哌嗪或哌啶的探索构建非共价肽基衍生物作为蛋白酶体抑制剂
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med State Key Lab Drug Res Shanghai;
Jiaxing Univ Coll Med Jiaxing 314001 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med State Key Lab Drug Res Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med State Key Lab Drug Res Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med State Key Lab Drug Res Shanghai;
Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med State Key Lab Drug Res Shanghai;
Hangzhou Xixi Hosp Dept Pharmaceut Preparat Hangzhou 310023 Zhejiang Peoples R China;
Proteasome inhibitors; Piperazine or piperidine; Non-covalent; Peptidyl derivatives; Anti-cancer;
机译:新型哌嗪或哌啶的探索构建非共价肽基衍生物作为蛋白酶体抑制剂
机译:新型非共价含哌啶的肽基蛋白酶体抑制剂的设计,合成和生物学评估
机译:二维哌啶和哌嗪衍生物作为乙酰胆碱酯酶酶抑制剂的二维和3D-QSAR研究
机译:P3和P4肽乙烯基酯衍生蛋白酶体抑制剂的位置分析
机译:第一部分。设计用于人类颗粒酶B(hBrB)的新型可逆非共价小分子抑制剂。第二部分。姜黄素和模拟物作为蛋白酶体抑制剂第三部分。新型的针对雌激素受体α的共激活因子结合抑制剂(CBI)的设计:打破1μM的障碍。
机译:新型取代的杂芳族哌嗪和哌啶衍生物作为人类肠道病毒71和柯萨奇病毒A16的抑制剂。
机译:新型取代的杂芳哌嗪和哌啶衍生物作为人肠道病毒71和柯萨奇病毒a16的抑制剂